The effectiveness removes the final regulatory hurdle for selling stockholders to trade shares. Monitor for any subsequent Form 4 filings indicating insider sales, which could create near-term selling pressure. The company's pre-revenue status and going-concern warning remain the dominant risk factors.
Price Chart
Executive Summary
The SEC declared effective Adaptin Bio's S-1 registration statement (File No. 333-298622) on September 9, 2026, covering the resale of 382,400 shares of common stock and 38,240 shares underlying placement agent warrants by selling stockholders. This is a procedural step for a pre-revenue biotech with a going-concern warning, and the effectiveness itself does not raise new capital for the company or alter its fundamentals, but it removes the last regulatory barrier before selling stockholders can begin trading shares, creating potential overhang.
Key Facts
- Effectiveness date: September 9, 2026, for S-1 File No. 333-298622.
- Registration covers 382,400 shares of common stock and 38,240 shares underlying placement agent warrants for resale by selling stockholders.
- Company is pre-revenue with a going-concern warning, developing APTN-101 (BRiTE platform) for glioblastoma.
- The S-1 was filed 13 days prior on August 28, 2026, and is now effective.
- No new capital is raised for the company from this effectiveness; only potential cash from warrant exercises.
Financial Impact
No new capital raised; potential future cash from warrant exercises is undisclosed and contingent.
Risk Factors
- Selling stockholders may begin selling shares immediately, creating overhang and downward price pressure.
- Pre-revenue biotech with a going-concern warning faces high risk of capital depletion before reaching commercialization.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002923 |
| Document: 9999999995-26-002923-index.html | 9999999995-26-002923 |
| Document: 9999999995-26-002923.txt | 9999999995-26-002923 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 6w ago | EFFECT | No price | awaiting T+20 | awaiting T+20 | No price |
Aug 28, 2026 8w ago | S-1 | No price | awaiting T+20 | awaiting T+20 | No price |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers